{
  "id": 7602224,
  "title": "Cancer drug pushes mutant blood stem cells to become short-lived immune cells",
  "url": "https://urgent.news/2026/09/15/cancer-drug-pushes-mutant-blood-stem-cells-to-become-short-lived",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T17:20:18.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-cancer-drug-mutant-blood-stem.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators. Because the broad activity of interferon-alpha can induce significant side effects, developing more focused strategies based on these mechanistic…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "South China Morning Post",
        "title": "Clues in the Blood: Solving the Mystery of Cancer of Unknown Origin",
        "url": "https://urgent.news/2026/09/15/clues-in-the-blood-solving-the-mystery-of-cancer-of-unknown-origin",
        "published": "2026-09-15T10:56:45.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}